170 related articles for article (PubMed ID: 36457973)
1. miR-23b-3p regulates differentiation of osteoclasts by targeting PTEN via the PI3k/AKT pathway.
Chai J; Xu L; Liu N
Arch Med Sci; 2022; 18(6):1542-1557. PubMed ID: 36457973
[TBL] [Abstract][Full Text] [Related]
2. miR-214 promotes osteoclastogenesis by targeting Pten/PI3k/Akt pathway.
Zhao C; Sun W; Zhang P; Ling S; Li Y; Zhao D; Peng J; Wang A; Li Q; Song J; Wang C; Xu X; Xu Z; Zhong G; Han B; Chang YZ; Li Y
RNA Biol; 2015; 12(3):343-53. PubMed ID: 25826666
[TBL] [Abstract][Full Text] [Related]
3. miR-363-3p is activated by MYB and regulates osteoporosis pathogenesis via PTEN/PI3K/AKT signaling pathway.
Li M; Luo R; Yang W; Zhou Z; Li C
In Vitro Cell Dev Biol Anim; 2019 May; 55(5):376-386. PubMed ID: 31025251
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-23b-3p promotes pancreatic cancer cell tumorigenesis and metastasis via the JAK/PI3K and Akt/NF-κB signaling pathways.
Zhang Y; Chen D; Zhang G; Wu X; Zhou L; Lin Y; Ding J; An F; Zhan Q
Oncol Lett; 2020 Nov; 20(5):160. PubMed ID: 32934728
[TBL] [Abstract][Full Text] [Related]
5. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.
Udagawa N; Takahashi N; Jimi E; Matsuzaki K; Tsurukai T; Itoh K; Nakagawa N; Yasuda H; Goto M; Tsuda E; Higashio K; Gillespie MT; Martin TJ; Suda T
Bone; 1999 Nov; 25(5):517-23. PubMed ID: 10574571
[TBL] [Abstract][Full Text] [Related]
6. Osteosarcoma Cell-Derived Small Extracellular Vesicles Enhance Osteoclastogenesis and Bone Resorption Through Transferring MicroRNA-19a-3p.
Luo T; Zhou X; Jiang E; Wang L; Ji Y; Shang Z
Front Oncol; 2021; 11():618662. PubMed ID: 33842319
[TBL] [Abstract][Full Text] [Related]
7. miR-140-3p aggregates osteoporosis by targeting PTEN and activating PTEN/PI3K/AKT signaling pathway.
Yin R; Jiang J; Deng H; Wang Z; Gu R; Wang F
Hum Cell; 2020 Jul; 33(3):569-581. PubMed ID: 32253621
[TBL] [Abstract][Full Text] [Related]
8. A potential therapeutic target for regulating osteoporosis via suppression of osteoclast differentiation.
Sun Q; Zhang B; Zhu W; Wei W; Ma J; Tay FR
J Dent; 2019 Mar; 82():91-97. PubMed ID: 30716449
[TBL] [Abstract][Full Text] [Related]
9. miR-142-5p promotes the osteoclast differentiation of bone marrow-derived macrophages via PTEN/PI3K/AKT/FoxO1 pathway.
Lou Z; Peng Z; Wang B; Li X; Li X; Zhang X
J Bone Miner Metab; 2019 Sep; 37(5):815-824. PubMed ID: 30900017
[TBL] [Abstract][Full Text] [Related]
10. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
11. Osteosarcoma-derived exosomal miR-501-3p promotes osteoclastogenesis and aggravates bone loss.
Lin L; Wang H; Guo W; He E; Huang K; Zhao Q
Cell Signal; 2021 Jun; 82():109935. PubMed ID: 33529755
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA miR-23b-3p promotes osteosarcoma by targeting ventricular zone expressed PH domain-containing 1 (VEPH1)/phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) pathway.
Fan L; Cao X; Lei Y
Bioengineered; 2021 Dec; 12(2):12568-12582. PubMed ID: 34903122
[TBL] [Abstract][Full Text] [Related]
13. The calcium channel TRPV6 is a novel regulator of RANKL-induced osteoclastic differentiation and bone absorption activity through the IGF-PI3K-AKT pathway.
Ma J; Zhu L; Zhou Z; Song T; Yang L; Yan X; Chen A; Ye TW
Cell Prolif; 2021 Jan; 54(1):e12955. PubMed ID: 33159483
[TBL] [Abstract][Full Text] [Related]
14. miR-346-3p promotes osteoclastogenesis via inhibiting TRAF3 gene.
Mao Y; Chen Y; Fu Y; Guan J; Liang M; Zhu Y; Yang F; Li F; Zhang Z; Wan C; Zhou P
In Vitro Cell Dev Biol Anim; 2020 Aug; 56(7):533-542. PubMed ID: 32839904
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-338-3p inhibits glucocorticoid-induced osteoclast formation through RANKL targeting.
Zhang XH; Geng GL; Su B; Liang CP; Wang F; Bao JC
Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706599
[TBL] [Abstract][Full Text] [Related]
16. GATA4-driven miR-206-3p signatures control orofacial bone development by regulating osteogenic and osteoclastic activity.
Guo S; Gu J; Ma J; Xu R; Wu Q; Meng L; Liu H; Li L; Xu Y
Theranostics; 2021; 11(17):8379-8395. PubMed ID: 34373748
[TBL] [Abstract][Full Text] [Related]
17. miR‑21 promotes osteoclastogenesis through activation of PI3K/Akt signaling by targeting Pten in RAW264.7 cells.
Wang S; Liu Z; Wang J; Ji X; Yao Z; Wang X
Mol Med Rep; 2020 Mar; 21(3):1125-1132. PubMed ID: 32016444
[TBL] [Abstract][Full Text] [Related]
18. Osteoclast signaling-targeting miR-146a-3p and miR-155-5p are downregulated in Paget's disease of bone.
Stephens E; Roy M; Bisson M; Nguyen HD; Scott MS; Boire G; Bouchard L; Roux S
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165852. PubMed ID: 32485219
[TBL] [Abstract][Full Text] [Related]
19. MiR-23b-3p promotes postmenopausal osteoporosis by targeting MRC2 and regulating the Wnt/β-catenin signaling pathway.
Li R; Ruan Q; Yin F; Zhao K
J Pharmacol Sci; 2021 Jan; 145(1):69-78. PubMed ID: 33357782
[TBL] [Abstract][Full Text] [Related]
20. Extracellular vesicles-encapsulated microRNA-29b-3p from bone marrow-derived mesenchymal stem cells promotes fracture healing via modulation of the PTEN/PI3K/AKT axis.
Yang J; Gao J; Gao F; Zhao Y; Deng B; Mu X; Xu L
Exp Cell Res; 2022 Mar; 412(2):113026. PubMed ID: 35026284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
